Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Vista, California 92083


Purpose:

This Phase IIb study is designed to assess the safety and efficacy of 0.005%, 0.01% and 0.015% PEP005 Topical Gel when applied to an area of skin, containing 4-8 AK lesions on the face or scalp.


Criteria:

Inclusion Criteria: - Must be male or female - Female patients must be of - Non-childbearing potential; - Childbearing potential, provided negative pregnancy test and using effective contraception - 4 to 8 AK lesions on the face or scalp Exclusion Criteria: - Cosmetic or therapeutic procedures within 2 weeks and within 2 cm of the selected treatment area. - Treatment with immunomodulators, or interferon/ interferon inducers or systemic medications that suppress the immune system: within 4 weeks. - Treatment with 5-FU, imiquimod, diclofenac, or photodynamic therapy: within 8 weeks and 2 cm of treatment area


NCT ID:

NCT00700063


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Vista, California 92083
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.